Atlantic Health Receives Historic $5 Million Endowment for Oncology Research Advancement
In a groundbreaking move for cancer research, Atlantic Health has announced the receipt of a historic $5 million endowment, marking the largest single donation the organization has ever received dedicated to oncology research. This significant pledge was made by Bruce I. Jacobs and Kenneth N. Levy, co-founders of Jacobs Levy Equity Management, on the occasion of their firm's 40th anniversary. The funds will establish a clinical research and innovation fund at the Atlantic Health Clinical Research and Innovation Institute (AHCRII), designed to accelerate groundbreaking research and enhance cancer treatments for patients.
The new endowment, known as the Jacobs Levy Clinical Research and Innovation Endowment, will generate sustainable annual income aimed at fostering innovative research that can dramatically improve patient outcomes within various Atlantic Health settings. According to Bruce Jacobs, the motivation behind this generous contribution stems from their firm’s long-standing belief in philanthropy's power to drive advancements in healthcare.
"This endowment signifies a transformational shift in cancer care in New Jersey," noted Jacobs. "It provides a sustainable resource that will allow Atlantic Health to pursue novel medical advances for the future."
Over the last 25 years, Jacobs Levy Equity Management has already made impressive contributions totaling $1.4 million toward initiatives supporting patient care, medical research, and community health programs, cementing their commitment to improving healthcare access. Previous contributions include gifts for genomic medicine, well-being services, and children's hospitals, demonstrating a robust history of philanthropy in the medical field.
The president and CEO of Atlantic Health, Saad Ehtisham, expressed gratitude for the foresight and generosity of Bruce Jacobs and Ken Levy, emphasizing that this endowment will allow Atlantic Health clinicians to advance their research efforts and enhance cancer care for communities well into the future. He articulated that the AHCRII was created to translate cutting-edge research into practical medical care standards, and this donation significantly bolsters that mission by accelerating the adoption of evidence-based discoveries in oncology.
The endowment will specifically fund high-impact oncology research projects, focusing on translating scientific advancements into innovative treatments and improved patient care models. This includes developing and evaluating novel therapies, technologies, and practices, as well as expanding access to clinical trials for patients battling various cancers. Importantly, it also aims to support early-stage research and initiatives that have the potential to evolve into extensive projects backed by external funding, partnerships, and commercialization efforts.
Atlantic Health has long maintained a steadfast commitment to research as an essential element of patient care. The institution's AHCRII serves as a beacon for patient-centered, innovative clinical research, striving to produce transformative impacts on patient outcomes and shape the future of personalized medical services. The institute’s portfolio includes a diverse range of clinical studies, from industry-led trials to those supported by federal initiatives, tackling a wide array of medical conditions including various cancers.
Noteworthy is that Atlantic Health is currently pioneering nearly 180 clinical trials recognized both nationally and internationally, encompassing early-phase studies on numerous cancer types including brain, breast, gastrointestinal, melanoma, multiple myeloma, and more. The strategic investment marked by this endowment places Atlantic Health at the forefront of oncology research, with hopes of delivering cutting-edge solutions to patients across New Jersey.
To learn more about the initiatives and research led by the Atlantic Health Clinical Research and Innovation Institute, or to access information on their comprehensive cancer care services, visit their official website.
About Jacobs Levy Equity Management
Founded in 1986, Jacobs Levy Equity Management is an independent firm based in Florham Park, New Jersey, specializing in managing public equity portfolios for institutional investors. The firm has gained recognition for its high-quality research and quantitative systems, being part of prominent investment lists globally.
About Atlantic Health
With a workforce exceeding 25,000 and over 5,600 affiliated physicians, Atlantic Health leads the way in providing quality healthcare across New Jersey, Pennsylvania, and the New York metropolitan area. The non-profit healthcare system offers extensive services and access points, ensuring that patients receive care tailored to their needs through numerous hospitals and specialized centers within the region.
The new endowment, known as the Jacobs Levy Clinical Research and Innovation Endowment, will generate sustainable annual income aimed at fostering innovative research that can dramatically improve patient outcomes within various Atlantic Health settings. According to Bruce Jacobs, the motivation behind this generous contribution stems from their firm’s long-standing belief in philanthropy's power to drive advancements in healthcare.
"This endowment signifies a transformational shift in cancer care in New Jersey," noted Jacobs. "It provides a sustainable resource that will allow Atlantic Health to pursue novel medical advances for the future."
Over the last 25 years, Jacobs Levy Equity Management has already made impressive contributions totaling $1.4 million toward initiatives supporting patient care, medical research, and community health programs, cementing their commitment to improving healthcare access. Previous contributions include gifts for genomic medicine, well-being services, and children's hospitals, demonstrating a robust history of philanthropy in the medical field.
The president and CEO of Atlantic Health, Saad Ehtisham, expressed gratitude for the foresight and generosity of Bruce Jacobs and Ken Levy, emphasizing that this endowment will allow Atlantic Health clinicians to advance their research efforts and enhance cancer care for communities well into the future. He articulated that the AHCRII was created to translate cutting-edge research into practical medical care standards, and this donation significantly bolsters that mission by accelerating the adoption of evidence-based discoveries in oncology.
The endowment will specifically fund high-impact oncology research projects, focusing on translating scientific advancements into innovative treatments and improved patient care models. This includes developing and evaluating novel therapies, technologies, and practices, as well as expanding access to clinical trials for patients battling various cancers. Importantly, it also aims to support early-stage research and initiatives that have the potential to evolve into extensive projects backed by external funding, partnerships, and commercialization efforts.
Atlantic Health has long maintained a steadfast commitment to research as an essential element of patient care. The institution's AHCRII serves as a beacon for patient-centered, innovative clinical research, striving to produce transformative impacts on patient outcomes and shape the future of personalized medical services. The institute’s portfolio includes a diverse range of clinical studies, from industry-led trials to those supported by federal initiatives, tackling a wide array of medical conditions including various cancers.
Noteworthy is that Atlantic Health is currently pioneering nearly 180 clinical trials recognized both nationally and internationally, encompassing early-phase studies on numerous cancer types including brain, breast, gastrointestinal, melanoma, multiple myeloma, and more. The strategic investment marked by this endowment places Atlantic Health at the forefront of oncology research, with hopes of delivering cutting-edge solutions to patients across New Jersey.
To learn more about the initiatives and research led by the Atlantic Health Clinical Research and Innovation Institute, or to access information on their comprehensive cancer care services, visit their official website.
About Jacobs Levy Equity Management
Founded in 1986, Jacobs Levy Equity Management is an independent firm based in Florham Park, New Jersey, specializing in managing public equity portfolios for institutional investors. The firm has gained recognition for its high-quality research and quantitative systems, being part of prominent investment lists globally.
About Atlantic Health
With a workforce exceeding 25,000 and over 5,600 affiliated physicians, Atlantic Health leads the way in providing quality healthcare across New Jersey, Pennsylvania, and the New York metropolitan area. The non-profit healthcare system offers extensive services and access points, ensuring that patients receive care tailored to their needs through numerous hospitals and specialized centers within the region.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.